$276 Million is the total value of WELCH CAPITAL PARTNERS LLC/NY's 51 reported holdings in Q1 2012. The portfolio turnover from Q4 2011 to Q1 2012 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2012 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2012-05-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIDERS INDEX | 45 | Q2 2024 | 52.7% |
Alphabet Inc-Cl C | 35 | Q2 2024 | 6.3% |
BLACKSTONE GROUP INC | 35 | Q2 2024 | 4.4% |
HUMANA INC | 32 | Q2 2024 | 5.9% |
Paypal Inc | 30 | Q2 2024 | 4.4% |
VANGUARD WORLD FDS | 28 | Q2 2024 | 43.6% |
CVS HEALTH CORP | 28 | Q4 2022 | 5.0% |
BRIGHT HORIZONS FAMILY SOLUTIONS INC | 26 | Q3 2019 | 4.5% |
SELECT SECTOR SPDR TR | 26 | Q2 2024 | 2.8% |
Proctor & Gamble | 26 | Q3 2019 | 0.9% |
View WELCH CAPITAL PARTNERS LLC/NY's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HEALTHTRONICS SURGICAL SERVICES INC | February 12, 2004 | 9 | 11.0% |
HMS HOLDINGS CORP | February 12, 2004 | 9 | 11.0% |
REGENERATION TECHNOLOGIES INC | February 12, 2004 | 9 | 11.0% |
SONUS PHARMACEUTICALS INC | February 12, 2004 | 9 | 11.0% |
DRAXIS HEALTH INC /CN/ | March 07, 2003 | 9 | 11.0% |
PRAECIS PHARMACEUTICALS INC | March 04, 2003 | 9 | 11.0% |
View WELCH CAPITAL PARTNERS LLC/NY's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-08-07 |
13F-HR | 2024-05-13 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-02 |
13F-HR | 2022-11-08 |
13F-HR | 2022-08-17 |
13F-HR | 2022-05-13 |
View WELCH CAPITAL PARTNERS LLC/NY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.